Schipperus, M.R.

patient t-cell transfusion platelet cd 4 þ study imatinib month signi ficantly group blood response hm patients signi transplantation count autologou ms patients leukemia hm patient data myeloid leukemia figure 12 months cell transplantation cytarabine treatment ficantly panel plasma reconstitution number trial phase grade storage subset ms patient data combination 3-7-rf storage time table infection tcrab event 3-7/d marrow transplant therapy expression result product myeloid randomized 24- h cci patient groups combination arm 1- h cci disease recovery cytokine responses cytogenetic pre-transplant data cd 95 expression b-cell protocol analysis complication vivo t-cell depletion difference fraction lymphocytes post transplant pathogen progression lymphoma range control center cycle 6 months